Drug Description in Trials / DrugBank / KEGG DRUG /

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Acylated and unacylated ghrelin dosages[1] Lenomorelin---[3] 193, 201, 202
2CC----[14] 13, 28, 46, 49, 51, 56, 84, 85, 96, 97, 98, 162, 202, 271
3DTR Melatonin (NIH CC PDS)[1] Melatonin[1] D08170 [2] MTNR1A,
MTNR1B 💬		[2] Circadian entrainment, Neuroactive ligand-receptor interaction 💬[1] 202
4Enviro-light artificial light box----[1] 202
5Ghrelin[1] Lenomorelin---[6] 6, 78, 193, 201, 202, 299
6Hourly dosing of the nychtemeral secretion of melatonin[1] Melatonin[1] D08170 [2] MTNR1A,
MTNR1B 💬		[2] Circadian entrainment, Neuroactive ligand-receptor interaction 💬[1] 202
7Melatonin[1] Melatonin[1] D08170 [2] MTNR1A,
MTNR1B 💬		[2] Circadian entrainment, Neuroactive ligand-receptor interaction 💬[12] 6, 8, 13, 37, 46, 49, 90, 97, 144, 145, 149, 202
8Melatonin CR[1] Melatonin[1] D08170 [2] MTNR1A,
MTNR1B 💬		[2] Circadian entrainment, Neuroactive ligand-receptor interaction 💬[1] 202
9Phototherapy (Bright Light)----[1] 202
10RM-493----[2] 193, 202
11Setmelanotide[1] Setmelanotide[1] D11927 [1] MC4R 💬[1] Neuroactive ligand-receptor interaction 💬[2] 202, 265
12Tasimelteon[1] Tasimelteon[1] D09388 [2] MTNR1A,
MTNR1B 💬		[2] Circadian entrainment, Neuroactive ligand-receptor interaction 💬[1] 202